GlaxoSmithKline Consumer Healthcare (Q2, YoY) Revenue rose 5.7 percent to Rs 1,345.1 crore. Net profit rose 25.3 percent to Rs 345.3 crore. Ebitda rose 11.9 percent to Rs 395.8 crore. Margin stood at 29.4 percent versus 27.8 percent.
'Consumer staples may see 0-18% earnings growth but unlikely to pass on tax-cut benefits' According to Kotak Institutional Equitie , companies under its universe may see 0-18 percent earnings growth in the current financial year.
Hold GlaxoSmithKline Consumer Healthcare target of Rs 7931: Sharekhan Sharekhan recommended hold rating on GlaxoSmithKline Consumer Healthcare with a target price of Rs 7931 in its research report dated August 05, 2019.
Market Headstart: Nifty likely to open lower; Bharti Airtel top sell idea Trends on SGX Nifty indicate a negative opening for the broader index in India, a with 0.46 percent loss or 50 points. Nifty futures were trading around 10,966-level on the Singaporean Exchange.
Stocks in the news: Bharti Airtel, SBI, ITC, Eicher Motors, Raymond, Tata Power, Tata Motors SBI | ITC | Eicher Motors | Raymond | Tata Power | ACC | Dishman Carbogen and SRF are stocks which are in the news today.
GSK Consumer Healthcare Q1 net profit up 24% to Rs 248 cr The company had posted a net profit of Rs 200.44 crore for the corresponding period of the previous fiscal, GlaxoSmithKline Consumer Healthcare said in a BSE filing.